Gabriel J. McCool

2020 Year In Review: Patent Decisions Impacting The Life Sciences

Finding The ‘Sweet Spot' Of Enablement In Amgen v. Sanofi: The Federal Circuit Provides Guidance On Enabling Antibody Claims

Expert Declarations In Inter Partes Review Proceedings Must Do More Than Create Noise: PTAB Silences Challenge To Patented Method For Cleaning "Noisy" Genetic Data

Targeting Indefinite Claims: Horizon Pharma, Inc. v. Dr. Reddy's Laboratories, Inc.

Not A Fragment Of The Imagination: Federal Circuit Decides In Favor Of Antibody Patent Owner In Hemlibra® Dispute

The Eagle Has Landed: Federal Circuit Affirms Disclosure-Dedication Doctrine Barring Doctrine Of Equivalents In Eagle Pharmaceuticals V. Slayback Pharma LLC

Illuminating Section 101: The Federal Circuit Upholds Diagnostic-Related Patent In Illumina, Inc. v. Ariosa Diagnostics, Inc.